Longevity
Epitalon
aka Epithalon · Epithalone · AEDG peptide · Ala-Glu-Asp-Gly · Epitalone · epitalon · epithalamin · epitalon peptide
Grade
Epitalon is a lab-made four-amino-acid peptide promoted as an anti-ageing telomere treatment, but the human evidence behind those claims is thin and largely from one research group.
- Class
- Synthetic pineal tetrapeptide (peptide bioregulator)
- Evidence
- Grade D · Animal data only
- Sport / WADA
- Not specifically listed by name on the WADA Prohibited List. Substances are not 'permitted' simply because they are unnamed; novel peptides can fall under broad catch-all categories, so athletes should treat it as high-risk.
- Last reviewed
- 2026-06
Grade D · Animal data only
Why this grade
The evidence base is overwhelmingly cell-culture and animal work, the bulk of it from a single Russian group (Khavinson and colleagues) and rarely independently replicated. The handful of human reports are small, old and methodologically weak. There is no robust human trial showing Epitalon extends lifespan, lengthens telomeres in living people, or treats any disease. This places it firmly at D: an interesting preclinical signal with negligible meaningful human evidence.
What is it?
Why people buy it
People buy it to slow ageing and live longer. Some also take it for better sleep.
What we actually know
- •It is a man-made tiny peptide, based on an extract from a small gland in the brain.
- •In lab dishes, it made the protective ends of genes (telomeres) longer. In some rat studies, fewer tumours appeared.
- •Some animal studies found it did not help them live longer on average.
- •Almost all of this work comes from one Russian group. Human studies are few, small and old. It is not a licensed medicine in the UK.
What might happen
- •There is no proof it slows ageing or makes you live longer in people.
- •Nobody knows the long-term risks. There is almost no safety data in people.
- •Cancer cells use the same process it is said to switch on. Some worry about cancer risk. This is a theory, not proven.
- •It is sold online as 'not for human use'. Nobody checks the bottle. Injecting carries infection risk.
- •It is not named as banned in sport, but it could still count as banned. Athletes should treat it as high-risk.
Bottom line
Interesting in lab dishes and mice, unproven in people. The big anti-ageing claims are not backed up.
Know someone taking this?
Send on WhatsAppIt is like a promising lab notebook that never made it out of the lab. Impressive results on cells in a dish and on mice, written up mostly by one team, but with the crucial does-it-work-in-people chapter still essentially blank.
How is it meant to work?
A synthetic tetrapeptide (Ala-Glu-Asp-Gly) modelled on a pineal-gland extract. Proposed to upregulate telomerase (hTERT), lengthen telomeres, modulate gene expression via direct peptide-DNA interaction, and restore pineal melatonin/circadian signalling. These mechanisms are demonstrated mostly in vitro; confirmation in living humans remains lacking.
What's it studied for?
Research contexts. Not proven uses, and not recommendations.
Does the human evidence stack up?
Genuinely thin. Despite decades of publications, human data are limited to a few small, old and methodologically weak studies, including retinitis pigmentosa cohorts and circadian/melatonin observations in elderly subjects. Almost all come from the Khavinson group. There are no modern, adequately powered, independently run randomised controlled trials, and no human study demonstrating telomere lengthening in living people or any extension of human lifespan or healthspan. The dramatic 'anti-ageing' claims rest on cell-culture and rodent work, not on humans.
What could go wrong?
- !Evidence dominated by a single Russian research group with limited independent replication
- !No modern, adequately powered human RCTs; longevity and telomere claims unproven in people
- !Some animal studies show no increase in mean lifespan, undercutting headline claims
- !Sold in the UK as an unlicensed research chemical / not for human consumption. No regulatory oversight of identity, purity, sterility or dose
- !Grey-market injectable products carry contamination, mislabelling and sterility risks
- !Long-term safety in humans is essentially unknown. Theoretical concern attaches to any agent claimed to activate telomerase, given telomerase's role in cancer cells
- !Marketing routinely overstates the evidence as if it were clinically established
Is it legal in the UK?
Not a licensed medicine in the UK and not approved by the MHRA for any use. It is not an authorised medicinal product, so any product making medical claims would contravene the Human Medicines Regulations 2012. In practice it is sold online as an unlicensed research chemical labelled not for human consumption, outside any pharmaceutical quality, safety or efficacy oversight. Supplying it for human use or marketing it with medicinal claims is unlawful.
Sources
- 01Overview of Epitalon - Highly Bioactive Pineal Tetrapeptide with Promising Properties — Bryl R, et al., International Journal of Molecular Sciences (2025)
Recent review; useful for showing the heavy imbalance toward preclinical data and the scarcity of human evidence.
- 02Effect of Epitalon on biomarkers of aging, life span and spontaneous tumor incidence in female Swiss-derived SHR mice — Anisimov VN, Khavinson VKh, et al., Biogerontology (2003)
Key rodent study; reported reduced tumour incidence and effects on ageing markers but no increase in mean lifespan in that cohort.
- 03Epitalon increases telomere length in human cell lines through telomerase upregulation or ALT activity — Al-Dulaimi S, et al., Biogerontology (2025)
Recent in-vitro work outside the Khavinson group - still cell-line data, not human evidence.
- 04Epitalon (Epithalon) - peptide bioregulator overview, Wikipedia
General background and summary of small human reports (e.g. retinitis pigmentosa); tertiary source, use only as orientation.
Related
Compare with
Before you trust a vial
Peptides are freeze-dried for a reason. If you have seen Epitalon sold pre-mixed in a ready-to-use pen or syringe, here is why that is a red flag for potency, sterility and dosing.
Storage & stability →Stay posted
Follow Epitalon
We'll email you only when Epitalon's evidence actually changes — a new human trial, a grade change, a safety signal. No spam, nothing for sale.